Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Single-blind Study on the Effects of Psychosomatic Symptom Interventions on Patients With Differentiated Thyroid Cancer During the Initial Treatment Period

NCT06422702 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT06422702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06422702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Single-blind Study on the Effects of Psychosomatic Symptom Interventions on Patients With Differentiated Thyroid Cancer During the Initial Treatment Period
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 1, 2023
Completion date
April 22, 2025
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ability to use a smartphone, all patients are in the initial treatment phase, normal cognitive and communicative abilities, capable of reading and understanding questionnaires in chinese, pathologically confirmed differentiated thyroid carcinoma, voluntary participation in the study and signed informed consent